Dataset
Suberoylanilide hydroxamic acid
Chemical Info
InChI | InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) |
---|---|
SMILES | C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO |
InChI Key | WAEXFXRVDQXREF-UHFFFAOYSA-N |
Molecular Formula | C14H20N2O3 |
Exact Mass | 264.147 g/mol |
Data and Resources
Metadata Information
Field | Value |
---|---|
DOI | |
License URL | https://creativecommons.org/licenses/by-sa/4.0 |
Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ01070155 |
Version | |
Author | |
Maintainer | |
Language | |
MetadataCreated | 2025-02-09T10:11:52.524502 |
MetadataModified | 2025-02-09T10:11:52.733552 |
MetadataPublished | 2024-06-14 |
Related Molecule |
Field | Value |
---|---|
Measurement Technique | liquid chromatography-mass spectrometry |
Measurement Variables |
Data-Source Molecule ID | Data-Source |
---|---|
1989084 | eMolecules |
5311 | PubChem |
45716 | ChEBI |
14823867 | PubChem: Thomson Pharma |
PD001323 | ProbesDrugs |
Vorinostat-(SAHA) | Selleck |
SCHEMBL9018 | SureChEMBL |
149647-78-9 | ACToR |
LSM-3828 | LINCS |
SAHA | Atlas |
vorinostat | Atlas |
NSC-701852 | clinicaltrials |
80021416 | NMRShiftDB |
MCULE-4234367506 | Mcule |
vorinostat | DailyMed |
CB3506806 | ChemicalBook |
217024 | Brenda |
HMDB0015568 | Human Metabolome Database |
151869 | Brenda |
41261 | Brenda |
7817 | Brenda |
1547 | Brenda |
PA164748224 | PharmGKB |
DB02546 | DrugBank |
CHEMBL98 | ChEMBL |
SHH | PDBe |
12015019 | PubChem: Drugs of the Future |
206568 | Brenda |
58IFB293JI | FDA SRS |
VORINOSTAT | DailyMed |
19149 | BindingDB |
VORINOSTAT | rxnorm |
MK-0683 | clinicaltrials |
MK0683 | clinicaltrials |
VORINOSTAT | clinicaltrials |
ZOLINZA | clinicaltrials |
HY-10221 | MedChemExpress |
237067 | Brenda |
DTXSID6041133 | EPA CompTox Dashboard |
4124 | DrugCentral |
ZINC000001543873 | ZINC |
6852 | Guide to Pharmacology |
J653.349C | Nikkaji |
IQILAW | CCDC |
ZOLINZA | rxnorm |
The data in this table is sourced from UniChem at EBI. |